PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Oct-2021 Pistoia Alliance President Warns Pharmaceutical Industry Not to Undo the Advances it has Made During the Pandemic The Pistoia Alliance
06-Oct-2021 Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine Johnson & Johnson
06-Oct-2021 Merck and Emmy-Nominated Actress Yvonne Orji Unveil Uncovering TNBC, Highlighting the Challenges Faced by Black Women Diagnosed with Triple-Negative Breast Cancer Merck
06-Oct-2021 New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies Thermo Fisher Scientific
06-Oct-2021 Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments Merck
06-Oct-2021 ViiV Healthcare submits FDA application for first dispersible single tablet regimen containing dolutegravir (DTG) for children living with HIV ViiV Healthcare
06-Oct-2021 Enterome to Attend Upcoming Conferences ENTEROME SA
06-Oct-2021 OXURION to Present at the Lytham Partners Fall 2021 Investor Conference OXURION
06-Oct-2021 Amber Implants VCFix® spinal system receives US FDA Breakthrough designation Amber Implants
06-Oct-2021 PureTech Founded Entity Vedanta Announces Positive Topline Phase 2 Data for VE303 in High-Risk C. difficile Infection and Exercise of $23.8 Million Option by BARDA PureTech
06-Oct-2021 New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications Janssen Pharmaceutical Companies of Johnson & Johnson
06-Oct-2021 Thermo Fisher Scientific Introduces On the Go mobile app in India Thermo Fisher Scientific
06-Oct-2021 Defence Therapeutics Inc.: DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Defence Therapeutics Inc.
06-Oct-2021 Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders RELIEF THERAPEUTICS Holding AG
05-Oct-2021 SYNLAB announces upward revision of FY'21 guidance SYNLAB AG
05-Oct-2021 Secarna Pharmaceuticals announces publication of new preclinical data showing strong potential of LNAplus(TM)-based ASOs to effectively treat diabetic kidney disease Secarna Pharmaceuticals GmbH & Co. KG
05-Oct-2021 Heiner Dreismann Joins Noscendo’s Board of Directors B3C newswire
05-Oct-2021 iOmx Therapeutics raises EUR 65 million in Series B round iOmx Therapeutics AG
05-Oct-2021 Gisèle Deblandre Joins Cellbox Solutions as CSO B3C newswire
04-Oct-2021 IGEA Pharma N.V.: GBC AG TO START EQUITY COVERAGE OF IGEA PHARMA IGEA Pharma N.V.